Showing results (141-150 of 286) with videos related to

Sort By:
Pageof 29
Plos One|April 5, 2013
5-Methoxyleoligin, a lignan from Edelweiss, stimulates CYP26B1-dependent angiogenesis in vitro and induces arteriogenesis in infarcted rat hearts in vivoBarbara Messner, Johann Kern, Dominik Wiedemann, et al.
Oncotarget|March 10, 2016
Biomarkers of evasive resistance predict disease progression in cancer patients treated with antiangiogenic therapiesAndreas Pircher, Karin Jöhrer, Florian Kocher, et al.
Frontiers in Immunology|April 3, 2023
A chemokine network of T cell exhaustion and metabolic reprogramming in renal cell carcinomaRenate Pichler, Peter J Siska, Piotr Tymoszuk, et al.
American Heart Journal|June 11, 2003
What is the role for improved long-term antiplatelet therapy after percutaneous coronary intervention?Steven Steinhubl, Peter Berger
Trends in Endocrinology and Metabolism: TEM|September 24, 2014
Pregnancy testing with hCG--future prospectsPeter Berger, Catharine Sturgeon
The Journal of Urology|January 29, 2008
Outcome after radical cystectomy with limited or extended pelvic lymph node dissectionNivedita Bhatta Dhar, Eric A Klein, Alwyn M Reuther, et al.
Cancer Causes & Control : CCC|September 20, 2008
Common genetic polymorphisms of AURKA and prostate cancer riskElisabeth Feik, Andreas Baierl, Stephan Madersbacher, et al.
European Urology|July 26, 2011
Contemporary management of lower urinary tract disease with botulinum toxin A: a systematic review of botox (onabotulinumtoxinA) and dysport (abobotulinumtoxinA)Altaf Mangera, Karl-Erik Andersson, Apostolos Apostolidis, et al.
Urology|October 26, 2010
Laparoscopic partial nephrectomy: a matched-pair comparison of the transperitoneal versus the retroperitoneal approachMartin Marszalek, Thomas Chromecki, Badereddin Mohamad Al-Ali, et al.
BJU International|January 17, 2013
Do differences in clinical symptoms and referral patterns contribute to the gender gap in bladder cancer?Armin Henning, Marlies Wehrberger, Stephan Madersbacher, et al.
Pageof 29